Viewing Study NCT00453557



Ignite Creation Date: 2024-05-05 @ 5:27 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00453557
Status: COMPLETED
Last Update Posted: 2016-12-08
First Post: 2007-03-27

Brief Title: Mechanism of Growth Hormone Effects on Adipose Tissue
Sponsor: Pennington Biomedical Research Center
Organization: Pennington Biomedical Research Center

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2016-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: GH
Brief Summary: Growth hormone treatment in humans has been shown to decrease body fat This study aims to determine what adipose tissue depots are affected by GH and what is the mechanism
Detailed Description: Growth hormone GH replacement in GH deficient adults results in an improvement in metabolic status an increase in lean body mass and a reduction in visceral adiposity GH might also decrease visceral adiposity in obese adults that are not GH deficient

The objective of the study is to determine the effects of GH on the metabolic syndrome and visceral adiposity in men with low blood levels of IGF-1 and the durability of these effects after stopping GH therapy We will use a double blind placebo controlled 6 month intervention trial followed by a blinded follow-up period of 6 months Thirty non-diabetic middle aged men with central adiposity BMI 27 kgm2 waist circumference 102 cm will participate

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None